DUBLIN, Dec. 4, 2020 /PRNewswire/ — The “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
The Global Regenerative Medicine Market is Projected to Reach USD 17.9 Billion by 2025 from USD 8.5 Billion in 2020, at a CAGR of 15.9% during the Forecast Period.
Market growth is driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products. However, the high cost of cell and gene therapies and ethical concerns related to the use of embryonic stem cells in research and development are expected to restrain the growth of this market during the forecast period.
The cell therapies segment accounted for the highest growth rate in the regenerative medicine market, by product, during the forecast period
Based on products, the regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The cell therapies segment accounted for the highest growth rate in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.
Oncology segment accounted for highest CAGR
Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. Agen judi terlengkap juga memiliki koleksi permainan slot online deposit via E-wallet dan all Bank yang paling banyak anda cari pemain game slot online seperti This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
18.104.22.168 Rising Prevalence of Chronic Diseases, Genetic Disorders, and Cancer
22.214.171.124 Rising Investments in Regenerative Medicine Research
126.96.36.199 Growing Pipeline of Regenerative Medicine Products
188.8.131.52 Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
184.108.40.206 High Cost of Cell and Gene Therapies
220.127.116.11 Implementation of the 21st Century Cures Act
18.104.22.168 Rising Demand for Organ Transplantations
5.3 Impact of the COVID-19 Pandemic on the Regenerative Medicine Market
6 Regenerative Medicine Market, by Product
6.2 Tissue-Engineered Products
6.2.1 Rising Prevalence of Chronic Wounds to Drive the Market Growth
6.3 Cell Therapies
6.3.1 Autologous Therapies
22.214.171.124 Autologous Therapies Segment to Register the Highest Growth in the Cell Therapies Market
6.3.2 Allogeneic Therapies
126.96.36.199 Rising Incidence of Chronic Conditions to Drive the Market Growth
6.4 Gene Therapies